Topics

Latest "Pilot And Phase 2 Study Of The Efficacy Of A Treatment Protocol With Dexamethasone Implant Loading Dose In Patients With Diabetic Macular Edema (LOADEX)" News Stories

05:11 EST 29th February 2020 | BioPortfolio

Here are the most relevant search results for "Pilot And Phase 2 Study Of The Efficacy Of A Treatment Protocol With Dexamethasone Implant Loading Dose In Patients With Diabetic Macular Edema (LOADEX)" found in our extensive news archives from over 250 global news sources.

More Information about Pilot And Phase 2 Study Of The Efficacy Of A Treatment Protocol With Dexamethasone Implant Loading Dose In Patients With Diabetic Macular Edema (LOADEX) on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Pilot And Phase 2 Study Of The Efficacy Of A Treatment Protocol With Dexamethasone Implant Loading Dose In Patients With Diabetic Macular Edema (LOADEX) for you to read. Along with our medical data and news we also list Pilot And Phase 2 Study Of The Efficacy Of A Treatment Protocol With Dexamethasone Implant Loading Dose In Patients With Diabetic Macular Edema (LOADEX) Clinical Trials, which are updated daily. BioPortfolio also has a large database of Pilot And Phase 2 Study Of The Efficacy Of A Treatment Protocol With Dexamethasone Implant Loading Dose In Patients With Diabetic Macular Edema (LOADEX) Companies for you to search.

Showing "Pilot Phase Study Efficacy Treatment Protocol With Dexamethasone" News Articles 1–25 of 45,000+

Saturday 29th February 2020

Innovative Treatments For Sleep Apnea Featured On “In Depth” With Host Laurence Fishburne

The educational program features experts discussing the evolution in Sleep Apnea treatment protocols. FORT LAUDERDALE, Fla. (PRWEB) February 29, 2020 “Deep Cover”, "Event Horizon", and "Platoon" star Laurence Fishburne is lending his skills as host to the educational television show “In Depth”. The "In Depth" series features a wide array of industry experts w...


Friday 28th February 2020

Evaluation of the economic impact of modified screening criteria for retinopathy of prematurity from the Postnatal Growth and ROP (G-ROP) study

Neonatal oxygen saturations and blood pressure at school-age in children born extremely preterm: a cohort study


Biogen, Sangamo Ink Neuro Deal for New “Gene Regulation” Therapies

Biogen is opening up its checkbook again to get its hands on innovative approaches to some brain disorders that have proven especially recalcitrant to new types of treatment. The Cambridge, MA-based neuroscience drug developer is paying gene editing company Sangamo Therapeutics (NASDAQ: SGMO) $350 million up front in a collaboration on potential one-time treatments for […]

Rare Disease Day- A patient organization leader perspective

Rare Disease Day, now Rare Disease Week, is a growing movement across the World, giving the rare global community a platform for patients to share their experiences collectively. PTEN patients are grateful for this opportunity. Kristin Anthony, President, and founder of the PTEN Foundation shared, "My wish for all rare disease families this rare disease day, reflect with gratitude, and move f...

The Quinism Foundation Calls on GSK to Take Action to Better Emphasize Limitations of Use for Krintafel® (Tafenoquine)

Despite Published CDC Recommendations, Krintafel® is Not Indicated by the FDA for Use in Presumptive Anti-Relapse Therapy WHITE RIVER JUNCTION, Vt. (PRWEB) February 28, 2020 The Quinism Foundation has sent correspondence to Evan Berland, at GlaxoSmithKline (GSK) Global Public Health, calling on GSK to take appropriate action to protect the health of asymptomatic U.S. travelers, including pro...

Florida law limiting first opioid prescription linked to drop in use

(Reuters Health) - A Florida law restricting the quantity of opioids a doctor can prescribe for acute pain to three days' worth may have led to overall reductions in opioids dispensed to patients in the state, a new study suggests.

NantHealth Reports 2019 Fourth-quarter, Full-year Financial Results

Q4 Financial Highlights 2019 vs 2018: Total revenue was $24.2 million, up 6% SaaS revenue was $18.4 million, up 6% Total gross margin increased to 63% from 50% Full-Year Financial Highlights 2019 vs 2018: Total revenue was $96.0 million, up 7% SaaS revenue was $72.8 million, up 11% Total gross margin increased to 60% from 51% Received Landmark FDA 510(k) Clearance for Omi...

Study on Positive Mental and Physical Health Outcomes for Veterans Released

A recent study finds that those who participate in Travis Manion Foundation initiatives more frequently, experience higher overall mental and emotional well-being. DOYLESTOWN, Pa. (PRWEB) February 28, 2020 In partnership Syracuse University's Institute of Veterans and Military Families (IVMF), Travis Manion Foundation (TMF) conducted their second annual study, which used a 10-question Brief I...

Meridian Clinical Research is a Finalist for Two Vaccine Industry Excellence Awards, Expects Elevated Demand for Vaccine Trials in 2020

Meridian Clinical Research, a leading investigative research network, is anticipating high demand for vaccine development this year. The company is a finalist to win the 2020 Vaccine Industry Excellence (ViE) award for Best Clinical Trial Site. Meridian is also the largest member of Platinum Research Network, which is a finalist for the Best Clinical Trial Network award. OMAHA, Neb. (PRWEB) Februa...

Baron & Budd Obtains $11,850,000 Settlement in False Claims Act Case Against Sanofi-Aventis U.S., LLC

Sanofi-Aventis must pay back millions of dollars in a False Claims Act case brought forward by a whistleblower Today, the nationally recognized attorneys from Baron & Budd obtained an $11,850,000 settlement in a case against pharmaceutical marketing company, Sanofi-Aventis U.S., LLC. The company markets drugs, including Lemtrada

ACOG Issues Guidance on Chronic Pelvic Pain

Treatment recommendations for CPP involve multidisciplinary approaches.

FDA approves a generic version of the drug Martin Shkreli monopolized

The FDA approved a generic version of Daraprim, the anti-infective treatment made famous when Martin Shkreli's company raised its price by more than 5,000%.

LucidHealth partners With Aidoc to bring advanced radiology AI to care sites in Midwest

LucidHealth, a physician-owned and led radiology company, announced today that it is using an AI-powered diagnostic aid from leading AI vendor Aidoc to help prioritize and expedite treatment The post LucidHealth partners With Aidoc to bring advanced radiology AI to care sites in Midwest appeared first on NS Medical Devices.

Grass Pollen Allergy Pipeline Review, H2 2019 [Published by Global Markets Direct] Prices from USD $1700

Grass Pollen Allergy Pipeline Review, H2 2019SummaryGlobal Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Grass Pollen Allergy Pipeline Review, H2 2019, provides an overview of the Grass Pollen Allergy Immunology pipeline landscape.Grass pollen allergy is a reaction which occurs soon after exposure to pollen from grasses. Signs and symptoms include skin reactions, s...

March Is National Colorectal Cancer Awareness Month

The latest information on screening, treatment advances and prevention of Colon and Rectal Cancer.

Ping An Launches COVID-19 Smart Image-Reading System to Help Control the Epidemic

HONG KONG and SHANGHAI, Feb. 28, 2020 /PRNewswire/ -- Ping An Insurance (Group) Company of China, Ltd. (hereafter "Ping An", the "Company" or the "Group", HKEX: 02318; SSE: 601318) announced that the Corona Virus Disease 2019 (COVID-19) smart image-reading system was launched on 19 February. It was developed by Ping An Smart Healthcare, the smart health care...

Vitamin D Tied to Back Problems in Postmenopausal Women

FRIDAY, Feb. 28, 2020 -- Vitamin D deficiency is associated with lumbar disc degeneration (LDD) and low back pain (LBP) in postmenopausal women, according to a study published online Feb. 10 in Menopause. Hao-Wei Xu, M.D., from Tongji University...

Statin Use May Reduce Mortality in High-Risk Prostate Cancer

FRIDAY, Feb. 28, 2020 -- Statin use alone or in combination with metformin is associated with lower all-cause and prostate cancer (PCa) mortality among high-risk patients, according to a study published online Feb. 8 in Cancer Medicine. Xiang-Lin...

HIV-Infected Youth Less Likely to Achieve Viral Suppression

FRIDAY, Feb. 28, 2020 -- Youth newly diagnosed with HIV are linked to care at similar rates as adults but achieve disproportionately lower rates of viral suppression, according to a study published online Jan. 28 in the Journal of Acquired Immune...

Age of Onset May Affect Clinical Outcomes for MS Patients on DMT

FRIDAY, Feb. 28, 2020 -- Age of onset for disease is an important factor affecting clinical outcomes across the life span in patients receiving disease-modifying therapy (DMT) for multiple sclerosis (MS), according to a study published online Feb....

Quarantine on cruise ship resulted in more coronavirus infected passengers

The cruise ship Diamond Princess was quarantined for over two weeks resulting in more coronavirus infected passengers than if they would have disembarked immediately. Rather the opposite to what was intended. This according to a study conducted at Umeå University in Sweden.

Dynamine® [NEW CLINICAL TRIAL]: Researchers discovered that Dynamine® extends caffeine’s half-life and increased its area under the curve approximately two-fold

Compound Solutions, Inc. and a university research partner have concluded a landmark clinical study demonstrating synergy between Dynamine® and caffeine, as well as Dynamine® and TeaCrine® in combination with caffeine. CARLSBAD, Calif. (PRWEB) February 28, 2020 SELF-AFFIRMED GRAS Dynamine®, is a rapid-onset energy and focus ingredient that increases perceived energy, alertness...

Rett syndrome-causing mutations compromise MeCP2-mediated liquid–liquid phase separation of chromatin

Nanobiotix 2019 Q4 and Annual Revenues

Regulatory News: NANOBIOTIX (Paris:NANO) (Euronext : NANO – ISIN : FR0011341205 – the ‘‘Company’’), a late clinical-stage nanomedicine company pioneering new approaches to the treatment of cancer, today announced its unaudited annual revenues for Q4 and the unaudited revenues for the year ended December 31, 2019. 2019 Revenues In K


Quick Search

News Quicklinks